Literature DB >> 17991645

Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with iron status in persons with type 2 diabetes mellitus.

Miguel Arredondo1, Denisse Jorquera, Elena Carrasco, Cecilia Albala, Eva Hertrampf.   

Abstract

BACKGROUND: High iron stores are known to cause type 2 diabetes mellitus in persons with hemochromatosis. However, it is not clear whether moderately elevated iron stores predict the risk of type 2 diabetes in healthy persons. Heme oxygenase (HO) 1 expression is increased when intracellular iron increases. Furthermore, HO shows a microsatellite polymorphism in its gene promoter that could be related to its expression and activity.
OBJECTIVES: We aimed to determine the length of (GT)(n) repeats in the HO1 gene promoter by using capillary electrophoresis and HO enzymatic activity in mononuclear cells (MNCs) from adult diabetes patients. We also aimed to assess the relation between these results and iron stores.
DESIGN: We studied 99 patients with type 2 diabetes mellitus and 90 nondiabetic (control) subjects. We determined iron status (serum iron, ferritin, and transferrin receptor), HO activity, and micropolymorphism.
RESULTS: One diabetes patient and 5 control subjects had iron deficiency anemia. No iron overload was detected in either group. Diabetes patients had significantly greater iron stores (P < 0.0001), total body iron (P < 0.001), and HO activity (P < 0.001) than did control subjects. A positive association between serum iron and HO activity was seen in the diabetes patients (P < 0.0001). Allelic frequency did not differ significantly between diabetes patients and control subjects; however, the frequency of the SM genotype was significantly higher and that of the SS and MM genotypes was significantly lower in the diabetes patients than in control subjects (P < 0.001 for all).
CONCLUSIONS: Type 2 diabetes patients carrying short (GT)(n) repeats may have higher ferritin values and greater HO enzymatic activity and may have greater susceptibility to diabetes than may those with long (GT)(n) repeats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991645     DOI: 10.1093/ajcn/86.5.1347

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  12 in total

1.  Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants.

Authors:  Hevidar Taha; Klaudia Skrzypek; Ibeth Guevara; Anneliese Nigisch; Stefan Mustafa; Anna Grochot-Przeczek; Pawel Ferdek; Halina Was; Jerzy Kotlinowski; Magdalena Kozakowska; Aneta Balcerczyk; Lucie Muchova; Libor Vitek; Guenter Weigel; Jozef Dulak; Alicja Jozkowicz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-27       Impact factor: 8.311

Review 2.  Haeme oxygenase signalling pathway: implications for cardiovascular disease.

Authors:  Laura E Fredenburgh; Allison A Merz; Susan Cheng
Journal:  Eur Heart J       Date:  2015-03-31       Impact factor: 29.983

3.  HMOX1 as a marker of iron excess-induced adipose tissue dysfunction, affecting glucose uptake and respiratory capacity in human adipocytes.

Authors:  José María Moreno-Navarrete; Francisco Ortega; Amaia Rodríguez; Jèssica Latorre; Sara Becerril; Mònica Sabater-Masdeu; Wifredo Ricart; Gema Frühbeck; José Manuel Fernández-Real
Journal:  Diabetologia       Date:  2017-02-27       Impact factor: 10.122

4.  Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter.

Authors:  Yohann Repessé; Ivan Peyron; Jordan D Dimitrov; Suryasarathi Dasgupta; Elika Farrokhi Moshai; Catherine Costa; Annie Borel-Derlon; Benoit Guillet; Roseline D'Oiron; Achille Aouba; Chantal Rothschild; Johannes Oldenburg; Anna Pavlova; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

5.  Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation.

Authors:  Huansheng Dong; Hu Huang; Xinxu Yun; Do-sung Kim; Yinan Yue; Hongju Wu; Alton Sutter; Kenneth D Chavin; Leo E Otterbein; David B Adams; Young-Bum Kim; Hongjun Wang
Journal:  Endocrinology       Date:  2014-01-01       Impact factor: 4.736

Review 6.  New insights into intracellular locations and functions of heme oxygenase-1.

Authors:  Louise L Dunn; Robyn G Midwinter; Jun Ni; Hafizah A Hamid; Christopher R Parish; Roland Stocker
Journal:  Antioxid Redox Signal       Date:  2014-02-28       Impact factor: 8.401

7.  Association of HMOX1 and NQO1 Polymorphisms with Metabolic Syndrome Components.

Authors:  Angélica Martínez-Hernández; Emilio J Córdova; Oscar Rosillo-Salazar; Humberto García-Ortíz; Cecilia Contreras-Cubas; Sergio Islas-Andrade; Cristina Revilla-Monsalve; Consuelo Salas-Labadía; Lorena Orozco
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

8.  Bilirubin Increases Insulin Sensitivity by Regulating Cholesterol Metabolism, Adipokines and PPARγ Levels.

Authors:  Jinfeng Liu; Huansheng Dong; Yong Zhang; Mingjun Cao; Lili Song; Qingjie Pan; Andrew Bulmer; David B Adams; Xiao Dong; Hongjun Wang
Journal:  Sci Rep       Date:  2015-05-28       Impact factor: 4.379

9.  Increased adipose tissue heme levels and exportation are associated with altered systemic glucose metabolism.

Authors:  José María Moreno-Navarrete; Amaia Rodríguez; Francisco Ortega; Sara Becerril; Mònica Sabater-Masdeu; Jessica Latorre; Wifredo Ricart; Gema Frühbeck; José Manuel Fernández-Real
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

10.  Repeat polymorphisms in the Homo sapiens heme oxygenase-1 gene in diabetic and idiopathic gastroparesis.

Authors:  Simon J Gibbons; Madhusudan Grover; Kyoung Moo Choi; Akhilesh Wadhwa; Adeel Zubair; Laura A Wilson; Yanhong Wu; Thomas L Abell; William L Hasler; Kenneth L Koch; Richard W McCallum; Linda A B Nguyen; Henry P Parkman; Irene Sarosiek; William J Snape; James Tonascia; Frank A Hamilton; Pankaj J Pasricha; Gianrico Farrugia
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.